The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties
Open accessAbstract
Predicting the response of a specific cancer to a therapy is a major goal in modern oncology that should ultimately lead to a personalised treatment. High-throughput screenings of potentially active compounds against a panel of genomically heterogeneous cancer cell lines have unveiled multiple relationships between genomic alterations and drug responses. Various computational approaches have been proposed to predict sensitivity based on genomic features, while others have used the chemical properties of the drugs to ascertain their effect. In an effort to integrate these complementary approaches, we developed machine learning models to predict the response of cancer cell lines to drug treatment, quantified through IC₅₀ values, based on both the genomic features of the cell lines and the chemical properties of the considered drugs. Models predicted IC₅₀ values in a 8-fold cross-validation and an independent blind test with coefficient of determination R² of 0.72 and 0.64 respectively. Furthermore, models were able to predict with comparable accuracy (R² of 0.61) IC50s of cell lines from a tissue not used in the training stage. Our in silico models can be used to optimise the experimental design of drug-cell screenings by estimating a large proportion of missing IC₅₀ values rather than experimentally measuring them. The implications of our results go beyond virtual drug screening design: potentially thousands of drugs could be probed in silico to systematically test their potential efficacy as anti-tumour agents based on their structure, thus providing a computational framework to identify new drug repositioning opportunities as well as ultimately be useful for personalized medicine by linking the genomic traits of patients to drug sensitivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Regularization and Variable Selection Via the Elastic Net
Zou, H., & Hastie, T. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00503.x · Cited by 20,957
Classification and Regression by randomForest
Liaw, A. I., & Wiener, M. C. (2007) · Cited by 18,594
Applied Multivariate Statistics for the Social Sciences
Stevens, J. P. (2012) · Routledge eBooks · doi:10.4324/9780203843130 · Cited by 10,648
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
A direct adaptive method for faster backpropagation learning: the RPROP algorithm
Riedmiller, M., & Braun, H. (2002) · IEEE International Conference on Neural Networks · doi:10.1109/icnn.1993.298623 · Cited by 3,917
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints
Yap, C. W. (2011) · Journal of Computational Chemistry · doi:10.1002/jcc.21707 · Cited by 2,962
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
Self-citationAn introduction to neural networks
(1998) · Choice Reviews Online · doi:10.5860/choice.35-5700 · Cited by 1,832
BRAF mutation predicts sensitivity to MEK inhibition
Solit, D. B., Garraway, L. A., Pratilas, C. A., Sawai, A., Getz, G., Basso, A., Ye, Q., Lobo, J. M., She, Y., Osman, I., et al. (2006) · Nature · doi:10.1038/nature04304 · Cited by 1,328
Cancer epigenetics reaches mainstream oncology
Rodríguez-Paredes, M., & Esteller, M. (2011) · Nature Medicine · doi:10.1038/nm.2305 · Cited by 1,205
Paull, K. D., Shoemaker, R. H., Hodes, L., Monks, A., Scudiero, D. A., Rubinstein, L., Plowman, J., & Boyd, M. R. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.14.1088 · Cited by 967
Reinhold, W. C., Sunshine, M., Liu, H., Varma, S., Kohn, K. W., Morris, J., Doroshow, J., & Pommier, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1370 · Cited by 887
The National Cancer Institute: cancer drug discovery and development program.
Grever, M. R., Schepartz, S. A., & Chabner, B. A. (1992) · PubMed · Cited by 722
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents
Sharma, S. V., Haber, D. A., & Settleman, J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2820 · Cited by 586
Subtype and pathway specific responses to anticancer compounds in breast cancer
Heiser, L. M., Sadanandam, A., Kuo, W.-L., Benz, S. C., Goldstein, T. C., Ng, S., Gibb, W. J., Wang, N. J., Ziyad, S., Tong, F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018854108 · Cited by 475
Cancer biomarkers: selecting the right drug for the right patient
Kelloff, G. J., & Sigman, C. C. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3651 · Cited by 251
Transcriptional data: a new gateway to drug repositioning?
Iorio, F., Rittman, T., Ge, H., Menden, M., & Saez-Rodriguez, J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.07.014 · Cited by 237
Self-citationMani, K. M., Lefebvre, C., Wang, K., Lim, W. K., Basso, K., Dalla‐Favera, R., & Califano, A. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.2 · Cited by 205
Kernels for small molecules and the prediction of mutagenicity, toxicity and anti-cancer activity
Swamidass, S. J., Chen, J., Bruand, J., Phung, P., Ralaivola, L., & Baldi, P. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti1055 · Cited by 192
Identifying Causal Genes and Dysregulated Pathways in Complex Diseases
Kim, Y.-A., Wuchty, S., & Przytycka, T. M. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001095 · Cited by 187
COMPARE: a web accessible tool for investigating mechanisms of cell growth inhibition
Zaharevitz, D. W., Holbeck, S. L., Bowerman, C., & Svetlik, P. A. (2002) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(01)00126-7 · Cited by 133
Ranking Chemical Structures for Drug Discovery: A New Machine Learning Approach
Agarwal, S., Dugar, D., & Sengupta, S. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci9003865 · Cited by 126
DEGAS: De Novo Discovery of Dysregulated Pathways in Human Diseases
Ulitsky, I., Krishnamurthy, A., Karp, R. M., & Ron Shamir, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013367 · Cited by 116
A modular approach for integrative analysis of large-scale gene-expression and drug-response data
Kutalik, Z., Beckmann, J. S., & Bergmann, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1397 · Cited by 113
Shi, L. M., Fan, Y., Myers, T. G., O'Connor, P. M., Paull, K. D., Friend, S. H., & Weinstein, J. N. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci970085w · Cited by 106
Park, E. S., Rabinovsky, R., Carey, M. S., Hennessy, B. T., Agarwal, R., Liu, W., Ju, Z., Deng, W., Lu, Y., Woo, H. G., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0743 · Cited by 99
Mining and Visualizing Large Anticancer Drug Discovery Databases
Shi, L. M., Fan, Y., Lee, J. K., Waltham, M. C., Andrews, D. T., Scherf, U., Paull, K. D., & Weinstein, J. N. (1999) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci990087b · Cited by 86
Harnessing gene expression to identify the genetic basis of drug resistance
Chen, B., Causton, H. C., Mancenido, D., Goddard, N. L., Perlstein, E. O., & Pe’er, D. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.69 · Cited by 52
Editorial: Computational methods for drug repurposing
Sanséau, P., & Koehler, J. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr047 · Cited by 43
Quantitative structure-activity relationships (QSAR) and molecular modelling in cancer research
Kubinyi, H. (1990) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01637071 · Cited by 42
Simplistic pathways or complex networks?
Jørgensen, C., & Linding, R. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.12.003 · Cited by 40
Large-Scale Elucidation of Drug Response Pathways in Humans
Silberberg, Y., Gottlieb, A., Kupiec, M., Ruppin, E., & Sharan, R. (2012) · Journal of Computational Biology · doi:10.1089/cmb.2011.0264 · Cited by 31
Liu, Y., & Ringnér, M. (2007) · Genome biology · doi:10.1186/gb-2007-8-5-r77 · Cited by 23
Using Expression and Genotype to Predict Drug Response in Yeast
Ruderfer, D. M., Roberts, D. C. K., Schreiber, S. L., Perlstein, E. O., & Kruglyak, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006907 · Cited by 15
Torkamani, A., & Schork, N. J. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.35 · Cited by 7
Cited by
Opportunities and obstacles for deep learning in biology and medicine
Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., Ferrero, E., Agapow, P.-M., Zietz, M., Hoffman, M. M., et al. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0387 · Cited by 2,310
Deep learning for computational biology
Angermueller, C., Pärnamaa, T., Parts, L., & Stegle, O. (2016) · Molecular Systems Biology · doi:10.15252/msb.20156651 · Cited by 1,473
“One typical application in biology is to predict the viability of a cancer cell line when exposed to a chosen drug (Menden et al , 2013; Eduati et al , 2015).”
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
Vora, L. K., Gholap, A. D., Jetha, K., Thakur, R. R. S., Solanki, H. K., & Chavda, V. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071916 · Cited by 1,061
Artificial intelligence in drug development: Present status and future prospects
Mak, K.-K., & Pichika, M. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.014 · Cited by 1,018
eD octor: machine learning and the future of medicine
Handelman, G. S., Kok, H. K., Chandra, R. V., Razavi, A. H., Lee, M. J., & Asadi, H. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12822 · Cited by 956
“The power of ML allows for this individualization at many levels: diagnosis [33], prognosis and treatment [34, 35].”
Background
Metadata
- Authors
- Menden, M. P., Iorio, F., Garnett, M., McDermott, U., Benes, C. H., Ballester, P. J., & Saez-Rodriguez, J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-04-30
- Volume
- 8
- Issue
- 4
- Pages
- e61318
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2129860849
- Cited by
- 542
- References
- 38
- FWCI
- 20.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.